Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$321K Hold
887
0.03% 147
2026
Q1
$312K Sell
887
-35
-4% -$12.5K 0.03% 146
2025
Q4
$302K Sell
922
-5
-0.5% -$1.59K 0.03% 149
2025
Q3
$262K Buy
927
+5
+0.5% +$1.45K 0.03% 149
2025
Q2
$257K Sell
922
-31
-3% -$8.78K 0.03% 147
2025
Q1
$297K Buy
953
+45
+5% +$13.3K 0.03% 140
2024
Q4
$237K Sell
908
-10
-1% -$2.97K 0.02% 149
2024
Q3
$296K Hold
918
0.03% 142
2024
Q2
$287K Hold
918
0.03% 140
2024
Q1
$261K Buy
918
+2
+0.2% +$585 0.03% 149
2023
Q4
$264K Sell
916
-15
-2% -$4.09K 0.03% 143
2023
Q3
$250K Buy
+931
New +$232K 0.03% 139
2022
Q2
Sell
-830
Closed -$201K 150
2022
Q1
$201K Sell
830
-60
-7% -$13.8K 0.02% 159
2021
Q4
$200K Buy
+890
New +$188K 0.02% 166
2021
Q3
Sell
-890
Closed -$217K 158
2021
Q2
$217K Sell
890
-6
-0.7% -$1.48K 0.03% 157
2021
Q1
$223K Hold
896
0.03% 155
2020
Q4
$206K Hold
896
0.03% 149
2020
Q3
$228K Hold
896
0.04% 122
2020
Q2
$212K Buy
+896
New +$204K 0.04% 118

Other funds holding AMGN

Bath Savings Trust's AMGN Position: Q2 2026 in Review

Bath Savings Trust held its Amgen (AMGN) position steady in Q2 2026 at 887 shares worth $321K. The position accounts for 0.03% of the portfolio, ranked #147.

Bath Savings Trust first reported a position in AMGN in Q2 2020 and has held it in 19 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bath Savings Trust held 887 shares of Amgen worth $321K as of Q2 2026.
  • Bath Savings Trust left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.03% of Bath Savings Trust's portfolio in Q2 2026, its #147 holding.
  • Bath Savings Trust first reported a position in Amgen in Q2 2020 and has held it in 19 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bath Savings Trust's 13F filing for Q2 2026, filed 9 Jul 2026.